Healthy volunteers test drug interaction in early-stage trial
NCT ID NCT07580586
First seen May 12, 2026 · Last updated May 22, 2026 · Updated 1 time
Summary
This early-stage study looks at whether a new drug called BV100 changes how the body handles another drug, polymyxin B. It involves 16 healthy adults who will receive both drugs in a set order. The goal is to measure drug levels and check for side effects, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Medical University of Vienna
RECRUITINGVienna, 1090, Austria
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.